Gene · 10347
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profound DNA methylomic differences between single- and multi-fraction alpha irradiations of lung fibroblasts. | Clin Epigenetics | 2023 | 37891670 | PubTator, text mining | PubMed |
| Structural Variation Detection and Association Analysis of Whole-Genome-Sequence Data from 16,905 Alzheimer's Diseases Sequencing Project Subjects. | Res Sq | 2023 | 37886469 | PubTator, text mining | PubMed |
| Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer. | Lipids Health Dis | 2023 | 37885013 | PubTator, text mining | PubMed |
| RNA-based translation activators for targeted gene upregulation. | Nat Commun | 2023 | 37884512 | PubTator, text mining | PubMed |
| Editorial: The UN international day of families: neurodegeneration as a result of genetic inheritance. | Front Aging Neurosci | 2023 | 37869370 | PubTator, text mining | PubMed |
| Prioritization of risk genes for Alzheimer's disease: an analysis framework using spatial and temporal gene expression data in the human brain based on support vector machine. | Front Genet | 2023 | 37867597 | PubTator, text mining | PubMed |
| Amyloid Precursor Protein and Alzheimer's Disease. | Int J Mol Sci | 2023 | 37834241 | PubTator, text mining | PubMed |
| Evaluation of the Polygenic Risk Score for Alzheimer's Disease in Russian Patients with Dementia Using a Low-Density Hydrogel Oligonucleotide Microarray. | Int J Mol Sci | 2023 | 37834213 | PubTator, text mining | PubMed |
| Anti-Amyloid Therapies for Alzheimer's Disease and the Amyloid Cascade Hypothesis. | Int J Mol Sci | 2023 | 37833948 | PubTator, text mining | PubMed |
| c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease. | BMC Med Genomics | 2023 | 37833700 | PubTator, text mining | PubMed |
| Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction. | Nat Commun | 2023 | 37833292 | PubTator, text mining | PubMed |
| Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease: A Potential Diagnostic Approach. | Neurology | 2023 | 37827850 | PubTator, text mining | PubMed |
| Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation. | Heliyon | 2023 | 37810022 | PubTator, text mining | PubMed |
| Early-onset Alzheimer's disease explained by polygenic risk of late-onset disease? | Alzheimers Dement (Amst) | 2023 | 37780862 | PubTator, text mining | PubMed |
| A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer's Disease Diagnosis Using Targeted Proteomics and Machine Learning. | Int J Mol Sci | 2023 | 37762058 | PubTator, text mining | PubMed |
| Interaction Analysis Reveals Complex Genetic Associations with Alzheimer's Disease in the CLU and ABCA7 Gene Regions. | Genes (Basel) | 2023 | 37761806 | PubTator, text mining | PubMed |
| Structural Variation Detection and Association Analysis of Whole-Genome-Sequence Data from 16,905 Alzheimer's Diseases Sequencing Project Subjects. | medRxiv | 2023 | 37745545 | PubTator, text mining | PubMed |
| ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia. | Nat Commun | 2023 | 37726279 | PubTator, text mining | PubMed |
| A landscape of complex tandem repeats within individual human genomes. | Nat Commun | 2023 | 37709751 | PubTator, text mining | PubMed |
| Cholesterol-dependent amyloid β production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol. | Cell Biosci | 2023 | 37705117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10347/papers?page=9